159 related articles for article (PubMed ID: 36599466)
41. Spindle cell lesion on fine needle aspiration as an initial step for diagnosis of lymphangioleiomyomatosis: Report of a rare case.
Manukyan I; Sidawy M; DeBrito P
Diagn Cytopathol; 2021 Sep; 49(9):E352-E355. PubMed ID: 34000096
[TBL] [Abstract][Full Text] [Related]
42. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.
Ferrans VJ; Yu ZX; Nelson WK; Valencia JC; Tatsuguchi A; Avila NA; Riemenschn W; Matsui K; Travis WD; Moss J
J Nippon Med Sch; 2000 Oct; 67(5):311-29. PubMed ID: 11031360
[TBL] [Abstract][Full Text] [Related]
43. Lymphangioleiomyomatosis: Current understanding and potential treatments.
Moir LM
Pharmacol Ther; 2016 Feb; 158():114-24. PubMed ID: 26713679
[TBL] [Abstract][Full Text] [Related]
44. Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration.
Chebib N; Archer F; Bobet-Erny A; Leroux C; Cottin V
Sci Rep; 2018 Oct; 8(1):14698. PubMed ID: 30279475
[TBL] [Abstract][Full Text] [Related]
45. Metastasis of benign tumor cells in tuberous sclerosis complex.
Henske EP
Genes Chromosomes Cancer; 2003 Dec; 38(4):376-81. PubMed ID: 14566858
[TBL] [Abstract][Full Text] [Related]
46. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene.
Maruyama H; Seyama K; Sobajima J; Kitamura K; Sobajima T; Fukuda T; Hamada K; Tsutsumi M; Hino O; Konishi Y
Mod Pathol; 2001 Jun; 14(6):609-14. PubMed ID: 11406664
[TBL] [Abstract][Full Text] [Related]
47. [Combination of pulmonary lymphangioleiomyomatosis (LAM) with angiomyolipoma (AML) of the kidney and multilocular cystic nephroma].
Sokolova IN; Gurariĭ DL; Kazantseva IA; Anurova OA; Chemeris GIu; Guterov SL; Zakharova TI; Rotin DL; Kharkin AA; Sorokin KV
Arkh Patol; 2004; 66(4):39-41. PubMed ID: 15449688
[TBL] [Abstract][Full Text] [Related]
48. [Pulmonary lymphangioleiomyomatosis. Morphologic and immunohistochemical findings].
Kuhnen C; Preisler K; Müller KM
Pathologe; 2001 May; 22(3):197-204. PubMed ID: 11402850
[TBL] [Abstract][Full Text] [Related]
49. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
[TBL] [Abstract][Full Text] [Related]
50. Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.
Prizant H; Hammes SR
Endocrinology; 2016 Sep; 157(9):3374-83. PubMed ID: 27409646
[TBL] [Abstract][Full Text] [Related]
51. Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.
Glasgow CG; Steagall WK; Taveira-Dasilva A; Pacheco-Rodriguez G; Cai X; El-Chemaly S; Moses M; Darling T; Moss J
Respir Med; 2010 Jul; 104 Suppl 1(Suppl 1):S45-58. PubMed ID: 20630348
[TBL] [Abstract][Full Text] [Related]
52. Clinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis.
Kinder B; McCormack FX
Lymphat Res Biol; 2010 Mar; 8(1):71-9. PubMed ID: 20235889
[TBL] [Abstract][Full Text] [Related]
53. Lymphangioleiomyomatosis: a study of 72 patients from the Spanish registry.
Antón E; Casanova A; Xaubet A; Román A; Villena V; Montero MC; Molina-Molina M; Pérez-Sánchez E; Sueiro A; Morell F; Girón RM; Ancochea J
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):85-91. PubMed ID: 20560288
[TBL] [Abstract][Full Text] [Related]
54. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex.
Moss J; Avila NA; Barnes PM; Litzenberger RA; Bechtle J; Brooks PG; Hedin CJ; Hunsberger S; Kristof AS
Am J Respir Crit Care Med; 2001 Aug; 164(4):669-71. PubMed ID: 11520735
[TBL] [Abstract][Full Text] [Related]
55. Roles of human epidermal growth factor receptor family in pulmonary lymphangioleiomyomatosis.
Kobayashi K; Miki Y; Saito R; Adachi K; Seyama K; Okada Y; Sasano H
Hum Pathol; 2018 Nov; 81():121-130. PubMed ID: 30030119
[TBL] [Abstract][Full Text] [Related]
56. Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.
Glasgow CG; El-Chemaly S; Moss J
Eur Respir Rev; 2012 Sep; 21(125):196-206. PubMed ID: 22941884
[TBL] [Abstract][Full Text] [Related]
57. Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.
Valencia JC; Pacheco-Rodriguez G; Carmona AK; Xavier J; Bruneval P; Riemenschneider WK; Ikeda Y; Yu ZX; Ferrans VJ; Moss J
Am J Respir Cell Mol Biol; 2006 Jul; 35(1):40-7. PubMed ID: 16474096
[TBL] [Abstract][Full Text] [Related]
58. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.
Karbowniczek M; Astrinidis A; Balsara BR; Testa JR; Lium JH; Colby TV; McCormack FX; Henske EP
Am J Respir Crit Care Med; 2003 Apr; 167(7):976-82. PubMed ID: 12411287
[TBL] [Abstract][Full Text] [Related]
59. Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors.
Inoue C; Miki Y; Saito-Koyama R; Kobayashi K; Seyama K; Okada Y; Sasano H
Pathol Res Pract; 2022 Feb; 230():153758. PubMed ID: 35026646
[TBL] [Abstract][Full Text] [Related]
60. [Clinical and molecular epidemiology of lymphangioleiomyomatosis and pulmonary pathology in tuberous sclerosis].
Urban T
Rev Mal Respir; 2000 Jun; 17(2 Pt 2):597-603. PubMed ID: 10939121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
